Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill amends section 1862(b)(1)(C) of the Social Security Act to clarify that group health plans may not differentiate benefits for individuals with end-stage renal disease (ESRD) or apply benefit limitations that disparately affect dialysis patients.
It expressly includes diagnosis or need for renal dialysis as a prohibited basis for differentiation, while also stating plans are not required to include particular dialysis providers or a specific number of such providers in their networks.
The Secretary is directed to enforce the provision consistent with nonconformance determination rules in 42 C.F.R. part 411.
Narrow, administrable change with patient-protection appeal; potential insurer/employer pushback and Senate procedural hurdles reduce chances.
Relative to its intended legislative type, this bill is a focused statutory amendment that clearly articulates its purpose and integrates with an existing enforcement framework, but it leaves important implementation details unspecified.
Progressives emphasize patient access and preventing cost-shifting
Progressives emphasize patient access and preventing cost-shifting
Likely supportive because the bill strengthens protections for a medically vulnerable group and prevents insurers from offloading costs onto Medicare.
Sees the clarification as closing an insurer loophole that could reduce access to dialysis.
May seek robust CMS enforcement and monitoring.
Generally favorable but cautious; supports protecting ESRD patients while balancing private plan design flexibility.
Wants clarity on legal standards, administrative enforcement, and potential cost impacts.
Would favor implementation details to avoid unintended consequences.
Likely skeptical because it constrains private plan benefit design and expands federal enforcement over insurers.
Concerned about increased costs, regulatory uncertainty, and litigation risk, though notes the bill preserves network composition discretion.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, administrable change with patient-protection appeal; potential insurer/employer pushback and Senate procedural hurdles reduce chances.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize patient access and preventing cost-shifting
Narrow, administrable change with patient-protection appeal; potential insurer/employer pushback and Senate procedural hurdles reduce chanc…
Relative to its intended legislative type, this bill is a focused statutory amendment that clearly articulates its purpose and integrates with an existing enforcement framework, but it leaves important implementation de…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.